Roivant Sciences Ltd. (ROIV) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Roivant Sciences Ltd. (ROIV): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 39/100 — a percentile rank of Roivant Sciences Ltd.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.
| Market cap | $25.6B |
| P / S | 3404.5× |
| EV / EBITDA | -17.9× |
| Gross margin | 100.0% |
| Operating margin | -7914.8% |
| Net margin | -5504.5% |
| Return on equity | -6.3% |
| ROIC | -23.2% |
| Revenue growth | -67.6% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Is Roivant Sciences Ltd. overvalued? P/S looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.
Independent of the events above — derived from Roivant Sciences Ltd.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact